lapatinib

You have access
A Systematic Review and Meta-analysis of the Combination of Vinorelbine and Lapatinib in Patients With Her2-positive Metastatic Breast Cancer
ATHINA STRAVODIMOU and IOANNIS A. VOUTSADAKIS

Anticancer Research July 2019, 39 (7) 3295-3301; DOI: https://doi.org/10.21873/anticanres.13471
You have access
Tyrosine Kinase Inhibitors Imatinib and Erlotinib Increase Apoptosis of Antimitotic Drug-resistant KBV20C Cells Without Inhibiting P-gp
JI YEONG KIM, HYUNG SIK KIM and SUNGPIL YOON

Anticancer Research July 2019, 39 (7) 3785-3793; DOI: https://doi.org/10.21873/anticanres.13527
You have access
Lapatinib Inhibits Amphiregulin-induced BeWo Choriocarcinoma Cell Proliferation by Reducing ERK1/2 and AKT Signaling Pathways
LETICIA VICOSA PIRES, YUYIN YI, JUNG-CHIEN CHENG, LOLITA SCHNEIDER PIZZOLATO, ELVIRA CORDERO, PETER C. K. LEUNG and ILMA SIMONI BRUM

Anticancer Research May 2019, 39 (5) 2377-2383; DOI: https://doi.org/10.21873/anticanres.13355
You have access
The C-Terminus of Hepatitis B Virus-encoded X Protein Is Required for Lapatinib Sensitivity in Hepatocellular Carcinoma Cells
JHEN-YU CHEN, WEI-CHIEN HUANG, CHING-TING WEI, PEI-HSUAN CHIEN and YUN-JU CHEN

Anticancer Research February 2019, 39 (2) 721-726; DOI: https://doi.org/10.21873/anticanres.13168
You have access
MMP9, Cyclin D1 and β-Catenin Are Useful Markers of p16-positive Squamous Cell Carcinoma in Therapeutic EGFR Inhibition In Vitro
CLAUDIA UMBREIT, PHILIPP ERBEN, ANNE FABER, RALF-DIETER HOFHEINZ, CHRISTOPH ADERHOLD, CHRISTEL WEISS, KARL HOERMANN, ANGELA WENZEL and JOHANNES DAVID SCHULTZ

Anticancer Research July 2015, 35 (7) 3801-3810;
You have access
Lapatinib-plus-Pegylated Liposomal Doxorubicin in Advanced HER2-positive Breast Cancer Following Trastuzumab: A Phase II Trial
MAGDALENA PIRCHER, BRIGITTE MLINERITSCH, MICHAEL A. FRIDRIK, CHRISTIAN DITTRICH, ALOIS LANG, EDGAR PETRU, ANSGAR WELTERMANN, JOSEF THALER, CLEMENS HUFNAGL, SIMON PETER GAMPENRIEDER, GABRIEL RINNERTHALER, SIGRUN RESSLER, HANNO ULMER and RICHARD GREIL

Anticancer Research January 2015, 35 (1) 517-521;
You have access
Immunohistochemical Features Associated with Sensitivity to Lapatinib-plus-Capecitabine and Resistance to Trastuzumab in HER2-positive Breast Cancer
YONGJUN CHA, SAE-WON HAN, HYESIL SEOL, DO-YOUN OH, SEOCK-AH IM, YUNG-JUE BANG, IN AE PARK, WONSHIK HAN, DONG-YOUNG NOH and TAE-YOU KIM

Anticancer Research August 2014, 34 (8) 4275-4280;

Main menu

User menu

Search

lapatinib